Photo: AP / Kirsty Wigglesworth, pool
LAHORE: The de Khon Global and its partners in the Netherlands and Turkey have reportedly reached the human testing phase in the development of a drug to treat Covid-19. According to a press release, the breakthrough has come from the VSY Biotechnology B.V., based in Netherlands, one of the strategic partner company of... read full story
Photo: Blood samples from coronavirus patients are prepared for analysis as part of the TACTIC-R trial, in the Blood Processing Lab in the Cambridge Institute of Therapeutic Immunology and Infectious Disease, in Cambridge, England, Thursday, May 21, 2020. The new trial known as TACTIC-R is testing whether existing drugs will help prevent the body's immune system from overreacting, which scientists hope could prevent organ failure and death in COVID-19 patients.
Ask about this article
Related Videos
Why Old Drugs Could Fight COVID-19
Covid-19 Drug Tests: We Have to Be Realistic, Sanofi Says
Possible ray of hope for coronavirus treatment l GMA
Ivermectin for COVID-19 (Corona virus) Treatment: Mechanism of action
